VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 64 filers reported holding VENTYX BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,821,536 | -33.4% | 340,384 | -37.1% | 0.25% | -22.0% |
| Q2 2023 | $17,744,275 | -9.5% | 540,984 | -7.5% | 0.32% | -16.4% |
| Q1 2023 | $19,597,500 | -35.4% | 585,000 | -36.8% | 0.38% | -33.6% |
| Q4 2022 | $30,330,750 | +286.1% | 925,000 | +311.1% | 0.58% | +297.3% |
| Q3 2022 | $7,855,000 | -50.2% | 225,000 | -82.5% | 0.15% | -49.0% |
| Q2 2022 | $15,768,000 | -9.9% | 1,289,280 | 0.0% | 0.29% | +0.7% |
| Q1 2022 | $17,496,000 | -31.7% | 1,289,280 | 0.0% | 0.28% | -13.7% |
| Q4 2021 | $25,605,000 | – | 1,289,280 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 686,370 | $23,837,630 | 31.65% |
| venBio Partners LLC | 758,800 | $26,353,124 | 7.47% |
| ACUTA CAPITAL PARTNERS, LLC | 205,377 | $7,132,743 | 4.78% |
| TCG Crossover Management, LLC | 815,724 | $28,330,095 | 4.17% |
| Integral Health Asset Management, LLC | 430,000 | $14,933,900 | 2.07% |
| Vivo Capital, LLC | 422,075 | $14,658,665 | 1.61% |
| Boxer Capital, LLC | 850,000 | $29,520,500 | 1.57% |
| Redmile Group, LLC | 929,900 | $32,295,427 | 1.54% |
| Logos Global Management LP | 225,000 | $7,814,250 | 1.04% |
| Birchview Capital, LP | 26,400 | $916,872 | 0.78% |